Advocacy intelligence hub — real-time data for patient organizations
Panretin: FDA approved
Topical treatment of cutaneous lesions in patients with AIDS-related Kaposi's sarcoma.
Taxol: FDA approved
For the second line treatment of AIDS-related Kaposi's sarcoma.
DaunoXome: FDA approved
First line cytotoxic therapy for advanced, HIV related Kaposi's sarcoma.
Intron A: FDA approved
Treatment of selected patients with AIDS-related Kaposi's sarcoma.
Roferon-A: FDA approved
Treatment of AIDS related Kaposi's sarcoma.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance4
Patient Assistance Programs3
Panretin
Advanz Pharma (US) Corp.
POMALYST�
Celgene Corporation
Doxil
Johnson & Johnson Pharmaceutical Research & Dev.
Panretin
(Alitretinoin)Orphan drugAdvanz Pharma (US) Corp.
Retinoid [EPC]
12.1 Mechanism of Action Alitretinoin (9-cis-retinoic acid) is a naturally occurring endogenous retinoid that binds to and activates all known intrace...
DaunoXome
(Daunorubicin citrate liposome injection)Orphan drugNeXstar Pharmaceuticals, Inc.
Roferon-A
(Interferon alfa-2a (recombinant))Orphan drugHoffmann-La Roche, Inc.
Intron A
(Interferon alfa-2b (recombinant))Orphan drugSchering Corporation
Doxil
(doxorubicin HCL liposome injection)Orphan drugstandardJohnson & Johnson Pharmaceutical Research & Dev.
12.1 Mechanism of Action The active ingredient of DOXIL liposomal infusion is doxorubicin hydrochloride. The mechanism of action of doxorubicin hydroc...
POMALYST�
(pomalidomide)Orphan drugacceleratedCelgene Corporation
Thalidomide Analog [EPC]
12.1 Mechanism of Action Pomalidomide is an analogue of thalidomide with immunomodulatory, antiangiogenic, and antineoplastic properties. Cellular act...